Thus, we propose that ATP11A may affect IPF and COVID-19 by functioning in both epithelial and myeloid cells and eliciting impaired cell death and immune pathways (Figure 10A). The gene discussed is ATP11A; the disease is idiopathic pulmonary fibrosis.